Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GC3111 vs Boostrix in Healthy Adults
NCT04238975Phase 2Unknown
- Sponsor
- GC Biopharma
- Start
- Oct 2019
- Primary completion
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GC3111 in Tetanus, diphtheria, pertussis, sponsored by GC Biopharma. Status: unknown.
02
Drugs
GC3111
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT04238975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238975.